Crossing the GenAI Chasm: From Potential to Real-World Impact

GenAI promises breakthrough productivity and transformative business impact—yet most organisations still fail to see meaningful results. Industry research shows that while up to 80% of companies experiment with GenAI, only about 5% successfully move beyond pilots into real, value generating deployments. This growing “GenAI Divide” is leaving many organisations stranded on the wrong side of innovation.

Why does this happen?
This is because implementing GenAI isn’t simply a matter of trying the latest LLM or chatbot. It requires organisations to cross a critical chasm—a transition from experimentation to enterprise grade adoption that many underestimate.

In this insightful session, we unpack:
The hidden reasons behind the 95% failure in achieving meaningful results.
From Parkinson’s Law on human nature, to high-cost measures (e.g. extensive man-in-the-loop) for anti-hallucination, or poor use cases & designs leading to such costs, as well as poor benefits-realisation management and other reasons, we break down the real obstacles organisations face today.

What separates organisations that succeed?
Learn how high performing adopters approach GenAI differently—including crucial differences in overcoming Parkinson’s Law, selecting appropriate use cases, cost-effective design and anti-hallucination measures, systematic benefits-realisation management and other best practices.

How to truly “Cross the GenAI Chasm”?
Join us on 24 April 2026 as we discover a practical framework for moving beyond pilots, enabling capable systems, and delivering sustained business impact.

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher NUS ISS